Johnson & Johnson

JNJNYSE

$265.04

Last price · USD

Market cap: $643.9B
P/E: 24.0x
EV / EBITDA: 16.4x
P/S: 6.8x
FCF yield: 3.1%
Div. yield: 1.92%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Johnson & Johnson balance sheet

Annual · USD millions except per-share data · 43 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	19,709	24,105	21,859	12,889	14,487	+8.0%
Short-term investments	393	417	1,068	9,392	17,121	-61.1%
Cash & short-term investments	20,102	24,522	22,927	22,281	31,608	-10.7%
Net receivables	17,178	18,927	14,873	16,915	18,984	-2.5%
Accounts receivable	17,178	14,842	14,873	14,039	15,283	+3.0%
Other receivables	0	4,085	0	2,876	3,701	—
Inventory	14,191	12,444	11,181	10,268	10,387	+8.1%
Prepaids	0	0	4,514	0	3,701	—
Other current assets	4,153	0	0	5,830	(3,701)	—
Total current assets	55,624	55,893	53,495	55,294	60,979	-2.3%
Non-current assets
Property, plant & equipment (net)	23,169	20,518	19,898	17,982	18,962	+5.1%
Goodwill	48,772	44,200	36,558	36,047	35,246	+8.5%
Intangible assets	50,403	37,618	34,175	38,489	46,392	+2.1%
Goodwill & intangible assets	99,175	81,818	70,733	74,536	81,638	+5.0%
Tax assets	6,874	10,461	9,279	8,947	10,223	-9.4%
Other non-current assets	14,368	11,414	14,153	30,619	10,216	+8.9%
Total non-current assets	143,586	124,211	114,063	132,084	121,039	+4.4%
Total assets	199,210	180,104	167,558	187,378	182,018	+2.3%
Current liabilities
Accounts payable	11,991	10,311	9,632	9,889	11,055	+2.1%
Other payables	1,388	3,772	2,993	2,220	1,112	+5.7%
Total payables	13,379	14,083	12,625	12,109	12,167	+2.4%
Short-term debt	8,495	5,983	3,451	12,756	3,766	+22.6%
Tax payables	0	3,772	2,993	2,220	1,112	—
Other current liabilities	4,534	4,126	3,993	6,639	3,586	+6.0%
Total current liabilities	54,126	50,321	46,282	55,802	45,226	+4.6%
Non-current liabilities
Long-term debt	39,438	30,651	25,881	26,886	29,985	+7.1%
Deferred tax liabilities (non-current)	6,791	2,448	3,193	3,991	7,487	-2.4%
Other non-current liabilities	17,311	25,194	23,428	23,895	25,297	-9.0%
Total non-current liabilities	63,540	58,293	52,502	54,772	62,769	+0.3%
Total debt	47,933	36,634	29,332	39,642	33,751	+9.2%
Total liabilities	117,666	108,614	98,784	110,574	107,995	+2.2%
Stockholders' equity
Common stock	3,120	3,120	3,120	3,120	3,120	0.0%
Retained earnings	168,978	155,791	153,843	128,345	123,060	+8.3%
Additional paid-in capital	0	0	153,843	128,345	123,060	—
Treasury stock	(75,624)	(75,680)	(75,662)	(41,694)	(39,099)	—
Accumulated other comprehensive income (loss)	(14,930)	(11,741)	(12,527)	(12,967)	(13,058)	—
Other stockholders' equity	0	0	(153,843)	(128,345)	(123,060)	—
Total stockholders' equity	81,544	71,490	68,774	76,804	74,023	+2.4%
Total equity	81,544	71,490	68,774	76,804	74,023	+2.4%
Total liabilities & equity	199,210	180,104	167,558	187,378	182,018	+2.3%
Additional fields
Accrued Expenses	27,718	26,129	26,213	24,298	25,707	+1.9%
Net Debt	28,224	12,529	7,473	26,753	19,264	+10.0%
Total Investments	393	417	1,068	9,392	17,121	-61.1%

Johnson & Johnson

JNJNYSE

$265.04

Last price · USD

Market cap: $643.9B
P/E: 24.0x
EV / EBITDA: 16.4x
P/S: 6.8x
FCF yield: 3.1%
Div. yield: 1.92%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Johnson & Johnson balance sheet

Annual · USD millions except per-share data · 43 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	19,709	24,105	21,859	12,889	14,487	+8.0%
Short-term investments	393	417	1,068	9,392	17,121	-61.1%
Cash & short-term investments	20,102	24,522	22,927	22,281	31,608	-10.7%
Net receivables	17,178	18,927	14,873	16,915	18,984	-2.5%
Accounts receivable	17,178	14,842	14,873	14,039	15,283	+3.0%
Other receivables	0	4,085	0	2,876	3,701	—
Inventory	14,191	12,444	11,181	10,268	10,387	+8.1%
Prepaids	0	0	4,514	0	3,701	—
Other current assets	4,153	0	0	5,830	(3,701)	—
Total current assets	55,624	55,893	53,495	55,294	60,979	-2.3%
Non-current assets
Property, plant & equipment (net)	23,169	20,518	19,898	17,982	18,962	+5.1%
Goodwill	48,772	44,200	36,558	36,047	35,246	+8.5%
Intangible assets	50,403	37,618	34,175	38,489	46,392	+2.1%
Goodwill & intangible assets	99,175	81,818	70,733	74,536	81,638	+5.0%
Tax assets	6,874	10,461	9,279	8,947	10,223	-9.4%
Other non-current assets	14,368	11,414	14,153	30,619	10,216	+8.9%
Total non-current assets	143,586	124,211	114,063	132,084	121,039	+4.4%
Total assets	199,210	180,104	167,558	187,378	182,018	+2.3%
Current liabilities
Accounts payable	11,991	10,311	9,632	9,889	11,055	+2.1%
Other payables	1,388	3,772	2,993	2,220	1,112	+5.7%
Total payables	13,379	14,083	12,625	12,109	12,167	+2.4%
Short-term debt	8,495	5,983	3,451	12,756	3,766	+22.6%
Tax payables	0	3,772	2,993	2,220	1,112	—
Other current liabilities	4,534	4,126	3,993	6,639	3,586	+6.0%
Total current liabilities	54,126	50,321	46,282	55,802	45,226	+4.6%
Non-current liabilities
Long-term debt	39,438	30,651	25,881	26,886	29,985	+7.1%
Deferred tax liabilities (non-current)	6,791	2,448	3,193	3,991	7,487	-2.4%
Other non-current liabilities	17,311	25,194	23,428	23,895	25,297	-9.0%
Total non-current liabilities	63,540	58,293	52,502	54,772	62,769	+0.3%
Total debt	47,933	36,634	29,332	39,642	33,751	+9.2%
Total liabilities	117,666	108,614	98,784	110,574	107,995	+2.2%
Stockholders' equity
Common stock	3,120	3,120	3,120	3,120	3,120	0.0%
Retained earnings	168,978	155,791	153,843	128,345	123,060	+8.3%
Additional paid-in capital	0	0	153,843	128,345	123,060	—
Treasury stock	(75,624)	(75,680)	(75,662)	(41,694)	(39,099)	—
Accumulated other comprehensive income (loss)	(14,930)	(11,741)	(12,527)	(12,967)	(13,058)	—
Other stockholders' equity	0	0	(153,843)	(128,345)	(123,060)	—
Total stockholders' equity	81,544	71,490	68,774	76,804	74,023	+2.4%
Total equity	81,544	71,490	68,774	76,804	74,023	+2.4%
Total liabilities & equity	199,210	180,104	167,558	187,378	182,018	+2.3%
Additional fields
Accrued Expenses	27,718	26,129	26,213	24,298	25,707	+1.9%
Net Debt	28,224	12,529	7,473	26,753	19,264	+10.0%
Total Investments	393	417	1,068	9,392	17,121	-61.1%